Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Austco HealthcareASX:AHC -4.26%58 EV-to-EBIT is 6.96 as of Jul. 24, 2026, which is 46% below its 10-year median of 12.88. GuruFocus rates ASX:AHC with a GF Score™ of 58/100 and a GF Value™ of A$0.33 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 465 Medical Devices & Instruments companies, Austco Healthcare ranks better than 86.24% on this metric.
The historical rank and industry rank for Austco Healthcare's EV-to-EBIT or its related term are showing as below:
ASX:AHC'
s EV-to-EBIT Range Over the Past 10 Years
Min: -5.68 Med: 12.88 Max: 219.33
Current: 6.96
During the past 13 years, the highest EV-to-EBIT of Austco Healthcare was 219.33. The lowest was -5.68. And the median was 12.88.
ASX:AHC's EV-to-EBIT is ranked better than 86.24% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 18.19
vs ASX:AHC: 6.96
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Austco Healthcare's Enterprise Value for the quarter that ended in Dec. 2025 was A$137.21 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austco Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$10.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austco Healthcare EV-to-EBIT Related Terms
Austco Healthcare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Austco Healthcare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Austco Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austco Healthcare EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austco Healthcare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Austco Healthcare's EV-to-EBIT falls into.
Austco Healthcare's current Enterprise Value is A$73.51 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austco Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$10.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austco Healthcare (ASX:AHC) has a EV-to-EBIT of 6.96 as of Jul. 24, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Austco Healthcare and its competitors. This is 46% below median its historical median of 12.88. According to the industry distribution chart, Austco Healthcare ranks #64 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 13.8%.
Is Austco Healthcare's EV-to-EBIT too high?
Austco Healthcare's current EV-to-EBIT of 6.96 is 46% below median its 10-year median of 12.88. The Medical Devices & Instruments industry median EV-to-EBIT is 18.19. Austco Healthcare's value of 6.96 is 61.7% below this industry median. Based on the distribution chart, Austco Healthcare ranks #64 out of 465 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Austco Healthcare has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Austco Healthcare's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Austco Healthcare ranks #64 out of 465 companies for EV-to-EBIT. This places Austco Healthcare in the top 14% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 18.19. Austco Healthcare's value of 6.96 is 61.7% below this benchmark. While the company's 10-year median is 12.88 vs. the industry median of 18.19, Austco Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.19, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austco Healthcare's current EV-to-EBIT of 6.96 is 61.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Austco Healthcare and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austco Healthcare's current EV-to-EBIT is 6.96, which is 46% below median its own 10-year median of 12.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austco Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Austco Healthcare (ASX:AHC) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.33, compared to a current price of A$0.23 — trading 31.8% below its estimated fair value. The current EV-to-EBIT is 6.96, which is 46% below median its 10-year median of 12.88 and 61.7% below the Medical Devices & Instruments industry median of 18.19. Austco Healthcare's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Austco Healthcare (ASX:AHC), the current EV-to-EBIT is 6.96 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austco Healthcare (ASX:AHC) Overvalued in 2026?
Based on GuruFocus' analysis, Austco Healthcare stock appears to be undervalued.
The current stock price of A$0.23 is trading 31.8% below its estimated GF Value™ of A$0.33.
GuruFocus considers Austco Healthcare to be Possible Value Trap.
Key valuation signals for ASX:AHC:
EV-to-EBIT: 6.96 (46% below median its 10-year median of 12.88)
GF Value™: A$0.33 vs. price of A$0.23 (31.8% below fair value)
Industry Position: 61.7% below the Medical Devices & Instruments median (#64 of 465)
No single metric tells the full story. See the ASX:AHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.
58GF Score
Get the complete analysis for ASX:AHC
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHC has been successfully added to your 
